Results 61 to 70 of about 5,855 (222)
cis–trans Isomerization of silybins A and B [PDF]
Methods were developed and optimized for the preparation of the 2,3-cis- and the 10,11-cis-isomers of silybin by the Lewis acid catalyzed (BF3∙OEt2) isomerization of silybins A (1a) and B (1b) (trans-isomers). The absolute configuration of all optically pure compounds was determined by using NMR and comparing their electronic circular dichroism data ...
Novotna, M. +9 more
openaire +4 more sources
The schematic diagram illustrated the proposed mechanism of DCPH in mouse macrophages. DCPH promotes autophagy to suppress the TLR4/NF‐κB/NLRP3 pathway and M1 polarization, thereby attenuating cellular oxidative stress and inflammation. ABSTRACT Gastric mucosal injury refers to the pathological changes characterized by congestion, edema, bleeding and ...
Yunyun Zhi +6 more
wiley +1 more source
ABSTRACT The aim of the study is to evaluate the therapeutic efficacy of Longchai Decoction (LCD), an empirical traditional Chinese medicine formula for liver disorders, on liver fibrosis (LF) and to elucidate its molecular mechanisms. A mouse model of LF and an erastin‐induced ferroptosis model was established in LX‐2 cells, which were then treated ...
Hui Wang +3 more
wiley +1 more source
This research examined the impacts of varying silybin dosages in high-lipid diets on the growth, hepatic histology, immunity, and immune-related gene expression of juvenile hybrid grouper (Epinephelus fuscoguttatus ♀ × Epinephelus lanceolatus ♂).
Mingsheng Xie +8 more
doaj +1 more source
Új antioxidáns hatású molekulák szintézise és hatásmechanizmusuk vizsgálata = Synthesis of novel antioxidants and investigation of mechanism of action [PDF]
A lilavirágú Máriatövisban található silybin és szintetikus származékainak antioxidáns hatását vizsgáltuk különböző rendszerekben (neutrofilek forbol-észter stimulálta szuperoxid anion termelés, xantin oxidáz aktivitás, gyökfogó képesség), azzal a céllal,
Antus, Sándor +2 more
core
Glucose addiction in cancer therapy : advances and drawbacks [PDF]
Glucose addiction in cancer therapy: advances and drawbacks.In contrast to differentiated normal cells, which primarily use mitochondrial respiration to generate the energy needed for cellular processes, most cancer cells rely on glycolysis, even in ...
Baltazar, Maria de Fátima Monginho +4 more
core +1 more source
Natural antioxidants and vascular calcification: a possible benefit? [PDF]
Background: Several studies have demonstrated the impact of vascular calcification on morbidity and mortality both in the general and chronic kidney disease populations.
Barrio-Vázquez, Sara +4 more
core
Total synthesis of (.+-.)-silybin, an antihepatotoxic flavonolignan.
The flavonolignan (±)-silybin (1), having an antihepatotoxic activity, has been synthesized via a key intermediate (9), which was prepared from readily available starting materials (2) and (3). The aldehyde (9) was transformed to the methoxymethyl ether (10), which was condensed with an acetophenone derivative (11) to yield the chalcone (12). Oxidation
H, Tanaka, M, Shibata, K, Ohira, K, Ito
openaire +3 more sources
The role of cytokines in ovarian cancer drug resistance
Abstract Ovarian cancer is the leading cause of death among women diagnosed with female reproductive system cancers. While significant advances have been made in treating various types of cancer, progress in ovarian cancer treatment over the past 20 years has been minimal, and the treatment course of ovarian cancer is not linear. Although many patients
Lu Wang +7 more
wiley +1 more source
Therapeutic Potential of Saikosaponins in MASLD and Cross‐Organ Protection: A Research Update
This review systematically outlines the multi‐target mechanisms of Saikosaponins (SSs) against MASLD, encompassing the regulation of lipid metabolism, insulin resistance, and inflammatory response. Furthermore, it highlights their novel cross‐organ protective effects on the cardiovascular, renal, and central nervous systems, providing therapeutic ...
Jiayao Xiong +5 more
wiley +1 more source

